retatrutide dosing trial safety clinical trials A new clinical from Eli Lilly and Company suggests its experimental retatrutide clinical trial dosing retatrutide
Description
[DOI] [PubMed] [Google Scholar] 192.Zhou J., Tang R., Wang X., Li X., Heianza Y., Qi L
Chin J Nat Med 2023;21:48398
Critical note: if diarrhea persists beyond two weeks or is accompanied by fever, blood in stool, or severe dehydration, contact your healthcare provider immediately
Resistance training, protein, and functional monitoring do all three
Reardon, S
16,17,18,19 As new indications continue to be developed, GLP-1 drugs demonstrate immense potential in the medical field, with future research expected to expand their therapeutic applications
